Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Ocular Therapeutix, Inc. (OCUL) had Debt to Capital Ratio of 0.21 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$10.70M |
|
$-64.05M |
|
$1.26M |
|
$9.44M |
|
$74.61M |
|
$-63.92M |
|
$-0.14M |
|
$-64.05M |
|
$-64.05M |
|
$-64.05M |
|
$-64.05M |
|
$-64.05M |
|
$-64.05M |
|
$-63.92M |
|
$-62.94M |
|
169.40M |
|
169.40M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$387.69M |
|
$10.78M |
|
$18.23M |
|
$405.92M |
|
$37.93M |
|
$69.20M |
|
$102.06M |
|
$139.99M |
|
$265.93M |
|
$265.93M |
|
$265.93M |
|
159.26M |
|
| Cash Flow Statement Financials | |
$-44.67M |
|
$-1.93M |
|
$4.18M |
|
$393.72M |
|
$351.30M |
|
$-42.42M |
|
$10.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.22 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.21 |
0.26 |
|
88.20% |
|
-597.47% |
|
-597.47% |
|
-- |
|
-598.74% |
|
-598.74% |
|
$-46.60M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.39 |
|
0.42 |
|
212.18 |
|
-24.09% |
|
-24.09% |
|
-15.78% |
|
-19.11% |
|
$1.67 |
|
$-0.28 |
|
$-0.26 |
|